Peter J. Worland
- Molecular Biology top 2%
- Oncology top 1%
- Cell Biology top 1%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Edward A. SausvilleGurmeet KaurLeonardo BrizuelaBradley A. CarlsonQizhi WangMichael D. LosiewiczWalter Filgueira de AzevedoS H Kim
- Topics
- Cancer-related Molecular Pathways (10 papers)Ubiquitin and proteasome pathways (7 papers)Radiopharmaceutical Chemistry and Applications (6 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Peter J. Worland
46 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 2.9k
- Oncology 2.4k
- Cell Biology 813
- Pulmonary and Respiratory Medicine 622
- Cancer Research 444
Countries citing papers authored by Peter J. Worland
This map shows the geographic impact of Peter J. Worland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Worland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Worland more than expected).
Fields of papers citing papers by Peter J. Worland
This network shows the impact of papers produced by Peter J. Worland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Worland. The network helps show where Peter J. Worland may publish in the future.
Co-authorship network of co-authors of Peter J. Worland
This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Worland. A scholar is included among the top collaborators of Peter J. Worland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Worland. Peter J. Worland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 124 | |
| 3 | 37 | |
| 4 | 45 | |
| 5 | 42 | |
| 6 | Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. | 215 |
| 7 | The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. | 298 |
| 8 | 9 | |
| 9 | 369 | |
| 10 | 41 | |
| 11 | Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. | 117 |
| 12 | 87 | |
| 13 | 285 | |
| 14 | 122 | |
| 15 | 17 | |
| 16 | 301 | |
| 17 | Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells. | 20 |
| 18 | 47 | |
| 19 | 93 | |
| 20 | 18 |
About Peter J. Worland
Peter J. Worland is a scholar working on Oncology, Cell Biology and Molecular Biology, having authored 46 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Oncology (2.4k citations), Cell Biology (813 citations) and Molecular Biology (2.9k citations). Peter J. Worland has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Edward A. Sausville, Gurmeet Kaur, Leonardo Brizuela, Bradley A. Carlson, Qizhi Wang, Michael D. Losiewicz, Walter Filgueira de Azevedo, S H Kim, Ursula Schulze‐Gahmen and Songqing Fan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.